| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/14/2004 | CN1134432C Omeprazole sodium salt |
| 01/14/2004 | CN1134265C Phosphazene polyelectrolytes as immunoadjuvants |
| 01/14/2004 | CN1134263C Liniment for repairing scratched face without residual scar |
| 01/14/2004 | CN1134262C Medicine for treating toothache and method for preparing the same |
| 01/14/2004 | CN1134258C Polymer coated tablet comprising amoxycillin and clavulanate |
| 01/14/2004 | CN1134254C Transdermal therapeutic system (TTS) contg. oxybutynin |
| 01/14/2004 | CN1134253C Oral slow-releasing opioid formulations and method for preparing the same |
| 01/13/2004 | USRE38385 Proteins, peptides, nucleosides, nucleotides; carrier carbohydrates and and sugars which are water soluble or water swellable and in a glassy amorphous state; storage stability |
| 01/13/2004 | US6678553 Device for enhanced delivery of biologically active substances and compounds in an organism |
| 01/13/2004 | US6677492 Sevoflurane |
| 01/13/2004 | US6677366 Methods, compositions and articles for reducing or preventing the effects of inflammation |
| 01/13/2004 | US6677362 Blending water insoluble drug with solvent-free polyvinylpyrrolidone carrier; dissolving nonionic surfactant and plasticizer; spraying; milling extrudate to powdery mass |
| 01/13/2004 | US6677361 Topical formulations for the transdermal delivery of niacin and methods of treating hyperlipidemia |
| 01/13/2004 | US6677346 Methods comprising intranasal morphine |
| 01/13/2004 | US6677342 Partial fatty acid oxidation inhibitors in the treatment of congestive heart failure |
| 01/13/2004 | US6677326 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration |
| 01/13/2004 | US6677323 Administering aerosol particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension to treat allergic rhinitis and asthma |
| 01/13/2004 | US6677322 Administering in the form of aerosolized particles, to treat lungs while minimizing systemic bioavailability; treating corticosteroid-responsive diseases such as asthma |
| 01/13/2004 | US6677320 Mixture with chelate compound; bone disorders |
| 01/13/2004 | US6677319 Phosphatidylcholine as medication with protective effect large intestinal mucosa |
| 01/13/2004 | US6677318 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 01/13/2004 | US6677313 Method for gene therapy using nucleic acid loaded polymeric microparticles |
| 01/13/2004 | US6677309 Anthracycline derivatives |
| 01/13/2004 | US6677304 Ophthalmic formulations |
| 01/13/2004 | US6676977 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 01/13/2004 | US6676972 Covalent microparticle-drug conjugates for biological targeting |
| 01/13/2004 | US6676970 Subcutaneous osteoporosis compositions |
| 01/13/2004 | US6676968 Release-regulating preparations comprising biphenyldiamine derivatives |
| 01/13/2004 | US6676967 Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia |
| 01/13/2004 | US6676966 Encased in polymeric film soluble at neutral to alkaline ph |
| 01/13/2004 | US6676965 Enteric coated formulation for bisphosphonic acids and salts thereof |
| 01/13/2004 | US6676964 Method for determining the three-dimensional structure of a protein |
| 01/13/2004 | US6676963 Ligand-targeted emulsions carrying bioactive agents |
| 01/13/2004 | US6676962 Patch having elastic backing layer inert to active substance and self adhesive matrix of drug, metal crosslinked poly-acrylate adhesive and fatty acid |
| 01/13/2004 | US6676961 Accomodates both small and large volume dosages |
| 01/13/2004 | US6676960 Intraoral adhesive preparation |
| 01/13/2004 | US6676959 Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption |
| 01/13/2004 | US6676958 Adjuvant composition for mucosal and injection delivered vaccines |
| 01/13/2004 | US6676956 Oil-in-water emulsion for protecting human organs against peroxidation |
| 01/13/2004 | US6676952 From the plant aucoumea klaineana of the family burseraceae; tree is also called ?okume?; cosmetics; imparts film-forming qualities |
| 01/13/2004 | US6676931 Buccal, polar and non-polar spray or capsule |
| 01/13/2004 | US6676930 Administering dose of mixture of lipid crystals comprising surfactant and spreading agnet as aerosol through an external airway of a mammal for enhancing mammalian eustachian tube lumen patency and pressure equalization performance |
| 01/13/2004 | US6676855 Ethyl nitrite; maintaining circulation to abdominal organs |
| 01/13/2004 | CA2242224C Sustained-release microgranules containing diltiazem as the active principle |
| 01/13/2004 | CA2102630C Pharmaceutical compositions of compacted medicaments |
| 01/08/2004 | WO2004003188A2 Stabilization of granules |
| 01/08/2004 | WO2004003145A2 Compositions and methods for modulating physiology of epithelial junctional adhesion molecules for enhanced mucosal delivery of therapeutic compounds |
| 01/08/2004 | WO2004003089A1 Edible inks for ink-jet printing on edible substrates |
| 01/08/2004 | WO2004003000A2 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections |
| 01/08/2004 | WO2004002999A2 Modified 2' and 3' -nucleoside produgs for treating flaviridae infections |
| 01/08/2004 | WO2004002941A1 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 01/08/2004 | WO2004002565A1 Minimally compliant, volume efficient piston for osmotic drug delivery systems |
| 01/08/2004 | WO2004002559A1 Method and packaging for pressurized containers |
| 01/08/2004 | WO2004002551A2 Inhalable epinephrine |
| 01/08/2004 | WO2004002549A1 Use of organic compounds |
| 01/08/2004 | WO2004002534A1 Use of dimethyl sulfone as isotonicity agent |
| 01/08/2004 | WO2004002533A1 Stable liquid parenteral parecoxib formulation |
| 01/08/2004 | WO2004002527A1 Compositions against chicken coccidiosis |
| 01/08/2004 | WO2004002475A1 Sustained release tablet containing indapamide |
| 01/08/2004 | WO2004002468A1 Method of producing a cationic liposomal preparation comprising a lipophilic compound |
| 01/08/2004 | WO2004002459A1 Hollow nanoparticle having modified cysteine residue and drug with the use thereof |
| 01/08/2004 | WO2004002458A1 Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability |
| 01/08/2004 | WO2004002456A1 Biodegradable block copolymeric compositions for drug delivery |
| 01/08/2004 | WO2004002455A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 01/08/2004 | WO2004002454A1 Camptothecin-carboxylate formulations |
| 01/08/2004 | WO2004002453A1 Method and apparatus for producing liposomes |
| 01/08/2004 | WO2004002451A1 Controllable released suppository used in milk-secreting channel |
| 01/08/2004 | WO2004002450A1 Coating suspensions (comprising osmopolymers, osmagents) for forming an expandable osmotic composition in controlled release dosage forms as well as the corresponding method for providing this osmotic coating |
| 01/08/2004 | WO2004002449A1 Controlled release of anti-arrhythmic agents |
| 01/08/2004 | WO2004002448A1 Oral dosage from comprising a liquid active agent formulation andcontrolling release thereof by an expandable osmotic composition |
| 01/08/2004 | WO2004002447A2 Dosage forms for increasing the solubility and extending the release of drugs such as e.g. topiramate and phenyton |
| 01/08/2004 | WO2004002446A1 Composition and method for cessation of nicotine cravings |
| 01/08/2004 | WO2004002445A2 Novel floating dosage form |
| 01/08/2004 | WO2004002444A2 A platform for transdermal formulations (ptf) |
| 01/08/2004 | WO2004002443A1 Solid dosage forms for rapid dissolution of poorly soluble drugs |
| 01/08/2004 | WO2004002440A1 Cosmetic composition for the skin containing melanotan ii and the use thereof as a suntan preparation |
| 01/08/2004 | WO2004002436A1 Biliquid foam entrapment |
| 01/08/2004 | WO2004002423A2 Cartilage enhancing food supplements with sucralose and methods of preparing the same |
| 01/08/2004 | WO2004002422A2 2’-c-methyl-3’-o-l-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections |
| 01/08/2004 | WO2004002414A2 Self-emulsifying formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability and/or reduced food effect |
| 01/08/2004 | WO2004002404A2 Compositions and method for enhanced mucosal delivery of interferon beta |
| 01/08/2004 | WO2004002402A2 Administration of acetylcholinesterase inhibitors to the cerebral spinal fluid |
| 01/08/2004 | WO2004002399A2 Use of gaba-c receptor antagonists for the treatment of myopia |
| 01/08/2004 | WO2004002398A2 Spherical pellet containing a water-soluble active ingredient |
| 01/08/2004 | WO2004002367A1 Drug eluting stent |
| 01/08/2004 | WO2004002320A2 Device and method for combining a treatment agent and a gel |
| 01/08/2004 | WO2004002225A1 System for encapsulating active principles, method for providing same and uses |
| 01/08/2004 | WO2003096874A3 Coated sustained release tablets of a hygroscopic compound for once-a-day therapy |
| 01/08/2004 | WO2003092647A3 Transport system in biological systems |
| 01/08/2004 | WO2003091387A3 Non-invasive delivery of polypeptides through the blood-brain barrier, and in vivo selection of endocytotic ligands |
| 01/08/2004 | WO2003090693A3 Pharmaceutical composition containing lamotrigine particles of defined morphology |
| 01/08/2004 | WO2003088880A3 Condom |
| 01/08/2004 | WO2003087174A3 Carbocyclic and oxacarbocyclic fumaric acid oligomers |
| 01/08/2004 | WO2003082241A3 Clarithromycin formulations having improved bioavailability |
| 01/08/2004 | WO2003080032A3 Pharmaceutical formulation for the active ingredient budesonide |
| 01/08/2004 | WO2003077845A3 Compositions and methods for treating glaucoma and ocular hypertension |
| 01/08/2004 | WO2003075842A3 Stable formulations of angiotensin converting enzyme (ace) inhibitors |
| 01/08/2004 | WO2003066205A3 Microcapsules having high carotenoid content |
| 01/08/2004 | WO2003057151A3 A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof |
| 01/08/2004 | WO2003055531A8 A hemostatic kit, a method of preparing a hemostatic agent and a method of promoting hemostasis |